148 related articles for article (PubMed ID: 27596294)
1. Evaluation of expression profiles of microRNAs and two target genes, FOXO3a and RUNX2, effectively supports diagnostics and therapy predictions in breast cancer.
Jurkovicova D; Magyerkova M; Sestakova Z; Copakova L; Bella V; Konecny M; Krivjanska M; Kulcsar L; Chovanec M
Neoplasma; 2016; 63(6):941-951. PubMed ID: 27596294
[TBL] [Abstract][Full Text] [Related]
2. Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease.
Taipaleenmäki H; Browne G; Akech J; Zustin J; van Wijnen AJ; Stein JL; Hesse E; Stein GS; Lian JB
Cancer Res; 2015 Apr; 75(7):1433-44. PubMed ID: 25634212
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA in breast cancer: The association with BRCA1/2.
Petrovic N; Davidovic R; Bajic V; Obradovic M; Isenovic RE
Cancer Biomark; 2017; 19(2):119-128. PubMed ID: 28128741
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
6. Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers.
Fkih M'hamed I; Privat M; Ponelle F; Penault-Llorca F; Kenani A; Bignon YJ
Cell Oncol (Dordr); 2015 Dec; 38(6):433-42. PubMed ID: 26392359
[TBL] [Abstract][Full Text] [Related]
7. Enforced expression of hsa-miR-125a-3p in breast cancer cells potentiates docetaxel sensitivity via modulation of BRCA1 signaling.
Xu X; Lv YG; Yan CY; Yi J; Ling R
Biochem Biophys Res Commun; 2016 Oct; 479(4):893-900. PubMed ID: 27693788
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA signatures in hereditary breast cancer.
Murria Estal R; Palanca Suela S; de Juan Jiménez I; Egoavil Rojas C; García-Casado Z; Juan Fita MJ; Sánchez Heras AB; Segura Huerta A; Chirivella González I; Sánchez-Izquierdo D; Llop García M; Barragán González E; Bolufer Gilabert P
Breast Cancer Res Treat; 2013 Nov; 142(1):19-30. PubMed ID: 24129975
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of traditional oncomiRs in plasma of breast cancer patients.
Jurkovicova D; Smolkova B; Magyerkova M; Sestakova Z; Kajabova VH; Kulcsar L; Zmetakova I; Kalinkova L; Krivulcik T; Karaba M; Benca J; Sedlackova T; Minarik G; Cierna Z; Danihel L; Mego M; Chovanec M; Fridrichova I
Oncotarget; 2017 Sep; 8(44):77369-77384. PubMed ID: 29100393
[TBL] [Abstract][Full Text] [Related]
10. The regulation and function of miR-21-FOXO3a-miR-34b/c signaling in breast cancer.
Liu X; Feng J; Tang L; Liao L; Xu Q; Zhu S
Int J Mol Sci; 2015 Jan; 16(2):3148-62. PubMed ID: 25647415
[TBL] [Abstract][Full Text] [Related]
11. Integration of BRCA1-mediated miRNA and mRNA profiles reveals microRNA regulation of TRAF2 and NFκB pathway.
Tanic M; Zajac M; Gómez-López G; Benítez J; Martínez-Delgado B
Breast Cancer Res Treat; 2012 Jul; 134(1):41-51. PubMed ID: 22167321
[TBL] [Abstract][Full Text] [Related]
12. rs15869 at miRNA binding site in BRCA2 is associated with breast cancer susceptibility.
Cao J; Luo C; Yan R; Peng R; Wang K; Wang P; Ye H; Song C
Med Oncol; 2016 Dec; 33(12):135. PubMed ID: 27807724
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA miR-335 is crucial for the BRCA1 regulatory cascade in breast cancer development.
Heyn H; Engelmann M; Schreek S; Ahrens P; Lehmann U; Kreipe H; Schlegelberger B; Beger C
Int J Cancer; 2011 Dec; 129(12):2797-806. PubMed ID: 21618216
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer.
Bertoli G; Cava C; Castiglioni I
Theranostics; 2015; 5(10):1122-43. PubMed ID: 26199650
[TBL] [Abstract][Full Text] [Related]
15. Regulation of breast cancer and bone metastasis by microRNAs.
Vimalraj S; Miranda PJ; Ramyakrishna B; Selvamurugan N
Dis Markers; 2013; 35(5):369-87. PubMed ID: 24191129
[TBL] [Abstract][Full Text] [Related]
16. Identification of direct target genes of miR-7, miR-9, miR-96, and miR-182 in the human breast cancer cell lines MCF-7 and MDA-MB-231.
Moazzeni H; Najafi A; Khani M
Mol Cell Probes; 2017 Aug; 34():45-52. PubMed ID: 28546132
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA deregulation in triple negative breast cancer reveals a role of miR-498 in regulating BRCA1 expression.
Matamala N; Vargas MT; González-Cámpora R; Arias JI; Menéndez P; Andrés-León E; Yanowsky K; Llaneza-Folgueras A; Miñambres R; Martínez-Delgado B; Benítez J
Oncotarget; 2016 Apr; 7(15):20068-79. PubMed ID: 26933805
[TBL] [Abstract][Full Text] [Related]
18. Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer.
Cheng CW; Chen PM; Hsieh YH; Weng CC; Chang CW; Yao CC; Hu LY; Wu PE; Shen CY
Oncotarget; 2015 Dec; 6(42):44222-38. PubMed ID: 26528854
[TBL] [Abstract][Full Text] [Related]
19. An oncogenic role of miR-592 in tumorigenesis of human colorectal cancer by targeting Forkhead Box O3A (FoxO3A).
Fu Q; Du Y; Yang C; Zhang D; Zhang N; Liu X; Cho WC; Yang Y
Expert Opin Ther Targets; 2016 Jul; 20(7):771-82. PubMed ID: 27167185
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-155 is involved in the pathogenesis of ulcerative colitis by targeting FOXO3a.
Min M; Peng L; Yang Y; Guo M; Wang W; Sun G
Inflamm Bowel Dis; 2014 Apr; 20(4):652-9. PubMed ID: 24583476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]